| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 311,566 | 353,138 | 352,569 | 356,295 | | Cost of Revenue | 37,811 | 44,993 | 46,599 | 56,402 | | | Gross Profit |
-
| 308,145 | 305,970 | 299,893 | | | Operating Expenses | | Research Development |
-
| (4,737) | 4,737 |
-
| | Selling General and Administrative | 126,549 | 178,396 | 130,128 | 147,186 | | Non Recurring | 13,176 | (5,013) | 5,013 | 1,668 | | Others | 94,402 | 157,694 | 107,917 | 101,292 | | | | Total Operating Expenses |
-
| 326,340 | 247,795 |
-
| | | | Operating Income or Loss |
-
| (18,195) | 58,175 | 49,747 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 39,628 | (18,195) | 58,175 | 49,747 | | Interest Expense | 21,604 | 25,779 | 26,608 | 30,685 | | Income Before Tax | 18,024 | (43,974) | 31,567 | 19,062 | | Income Tax Expense | 2,030 | (26,633) | (11,158) | 2,203 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,994 | (17,341) | 42,725 | 16,859 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,994 | (17,341) | 42,725 | 16,859 | | Preferred Stock And Other Adjustments | (7,342) | (7,331) | (7,321) | (3,250) | | | Net Income Applicable To Common Shares | $8,652 | ($24,672) | $35,404 | $13,609 |
|
0.51% Nasdaq 
Income Statement
